Current concepts: immunology. Monocytes and macrophages.

MACROPHAGES play a central and essential part in the immune response by presenting antigen to lymphocytes during the development of specific immunity and by serving as supportive, "accessory" cells...

[1]  S. Reed,et al.  Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma , 1987, The Journal of experimental medicine.

[2]  J. David,et al.  Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages , 1987, The Journal of experimental medicine.

[3]  C. Sieff.  Hematopoietic growth factors. , 1987, The Journal of clinical investigation.

[4]  E. Unanue,et al.  The basis for the immunoregulatory role of macrophages and other accessory cells. , 1987, Science.

[5]  M. Kaplan,et al.  In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. , 1987, Journal of immunology.

[6]  K. Welte,et al.  Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. , 1987, Journal of immunology.

[7]  D. Komp.  Langerhans cell histiocytosis. , 1987, New England Journal of Medicine.

[8]  B. Beutler,et al.  Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.

[9]  Y. Hannun,et al.  Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. , 1987, Science.

[10]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[11]  C. Black,et al.  In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma. , 1987, Journal of immunology.

[12]  B. Rouse,et al.  Immunosuppression in Viral Infections , 1986, Reviews of infectious diseases.

[13]  H. Gendelman,et al.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.

[14]  J. Remington,et al.  Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. , 1986, Journal of immunology.

[15]  R. Steinman,et al.  Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. , 1986, The New England journal of medicine.

[16]  O. Runquist,et al.  Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction. , 1986, Journal of immunology.

[17]  S. Douglas,et al.  Phagocytic defects--monocytes/macrophages. , 1986, Clinical immunology and immunopathology.

[18]  A. Zlotnik,et al.  Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. , 1986, Journal of immunology.

[19]  R. Strunk,et al.  Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. , 1986, Journal of Immunology.

[20]  S. Reed,et al.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. , 1985, The Journal of clinical investigation.

[21]  C. Nathan,et al.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. , 1985, Journal of immunology.

[22]  S. Gordon,et al.  Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone. , 1985, The Journal of clinical investigation.

[23]  J. Virelizier,et al.  Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality. , 1985, Journal of immunology.

[24]  A. Fauci,et al.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. , 1984, The Journal of clinical investigation.

[25]  R. Kimberly,et al.  Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. , 1984, Journal of immunology.

[26]  R. Furth,et al.  Characteristics and Functional Capacities of Human Cord Blood Granulocytes and Monocytes , 1984, Pediatric Research.

[27]  R. Mertelsmann,et al.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma , 1984, Journal of Experimental Medicine.

[28]  M. Hobbs,et al.  Recombinant human gamma-interferon induces human monocyte polykaryon formation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Masur,et al.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.

[30]  R. Johnston,et al.  Functional and biochemical studies of multinucleated giant cells derived from the culture of human monocytes , 1984, Journal of Experimental Medicine.

[31]  R. Polin,et al.  Decreased Fibronectin Biosynthesis by Human Cord Blood Mononuclear Phagocytes In Vitro , 1984, Journal of leukocyte biology.

[32]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[33]  T. Springer,et al.  Deficiency of a surface membrane glycoprotein (Mo1) in man. , 1984, The Journal of clinical investigation.

[34]  S. Kaufmann,et al.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon , 1984, European Journal of Immunology.

[35]  T. Manser,et al.  Effect of IFN-γ on the immune response in vivo and on gene expression in vitro , 1984, Nature.

[36]  G. Trinchieri,et al.  IMMUNE INTERFERON INDUCES THE RECEPTOR FOR MONOMERIC IgGI ON HUMAN MONOCYTIC AND MYELOID CELLS* , 2003 .

[37]  Mills El.  Mononuclear phagocytes in the newborn: their relation to the state of relative immunodeficiency. , 1983 .

[38]  C. Nathan,et al.  Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells , 1982, The Journal of experimental medicine.

[39]  S. Yen,et al.  Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis. , 1982, Cellular Immunology.

[40]  R. Snyderman,et al.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. , 1981, The Journal of clinical investigation.

[41]  S. Gordon,et al.  Surface properties of bacillus Calmette-Guerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia , 1981, The Journal of experimental medicine.

[42]  J. Groopman,et al.  The histiocytic disorders: a pathophysiologic analysis. , 1981, Annals of internal medicine.

[43]  R. Johnston,et al.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide , 1980, Journal of Experimental Medicine.

[44]  L. Zwelling,et al.  DEFECTIVE MONOCYTE KILLING IN PATIENTS WITH MALIGNANCIES AND RESTORATION OF FUNCTION DURING CHEMOTHERAPY , 1980, The Lancet.

[45]  E. R. Stiehm,et al.  Deficiency of immune interferon production by leukocytes of normal newborns. , 1980, Cellular immunology.

[46]  R. van Furth,et al.  Characteristics of human mononuclear phagocytes. , 1979, Blood.

[47]  R. Gale,et al.  Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. , 1978, Science.

[48]  R. North.  Opinions: The Concept of the Activated Macrophage , 1978 .

[49]  Z. Cohn.  Activation of mononuclear phagocytes: fact, fancy, and future. , 1978, Journal of immunology.

[50]  M. L. Karnovsky,et al.  Biochemical criteria for activated macrophages. , 1978, Journal of immunology.

[51]  D. S. Gordon,et al.  Surface membrane characteristics and cytochemistry of the abnormal cells in adult acute leukemia. , 1978, Blood.

[52]  S. Klebanoff,et al.  Depressed mononuclear leukocyte chemotaxis in thermally injured patients. , 1977, Journal of immunology.

[53]  R. Johnston,et al.  Chronic granulomatous disease. , 1977, Pediatric clinics of North America.

[54]  R. Blaese,et al.  Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. , 1976, Blood.

[55]  D. Golde,et al.  Direct evidence for a bone marrow origin of the alveolar macrophage in man. , 1976, Science.

[56]  D. Zucker‐Franklin.  Physiological and pathological variations in the ultrastructure of neutrophils and monocytes. , 1975, Clinics in Haematology.

[57]  S. Balcerzak,et al.  Effects of corticosteroid therapy on human monocyte function. , 1975, The New England journal of medicine.

[58]  G. Meuret,et al.  Kinetics of human monocytopoiesis. , 1974, Blood.

[59]  A. Fauci,et al.  Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. , 1974, The New England journal of medicine.

[60]  D. Whitelaw.  OBSERVATIONS ON HUMAN MONOCYTE KINETICS AFTER PULSE LABELING , 1972, Cell and tissue kinetics.

[61]  R. van Furth,et al.  The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. , 1972, Bulletin of the World Health Organization.

[62]  Mackaness Gb.  The monocyte in cellular immunity. , 1970 .

[63]  Dall Jl,et al.  MORE ACID/BASE DISTURBANCES. , 1963 .